These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22470899)

  • 1. The impact of policy and screening on cervical cancer in England.
    Bryant E
    Br J Nurs; 2012 Feb 23-Mar 7; 21(4):S4, S6-10. PubMed ID: 22470899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the impact of screening policy and screening compliance on incidence and mortality of cervical cancer in the post-HPV vaccination era.
    de Blasio BF; Neilson AR; Klemp M; Skjeldestad FE
    J Public Health (Oxf); 2012 Dec; 34(4):539-47. PubMed ID: 22707556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.
    Franco EL; Cuzick J; Hildesheim A; de Sanjosé S
    Vaccine; 2006 Aug; 24 Suppl 3():S3/171-7. PubMed ID: 16844268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting cervical screening after introduction of the human papillomavirus vaccine: the effect of repeated mass media campaigns.
    Mullins R; Coomber K; Broun K; Wakefield M
    J Med Screen; 2013 Mar; 20(1):27-32. PubMed ID: 23514877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
    Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and prevention: cervical cancer.
    Weinstein LC; Buchanan EM; Hillson C; Chambers CV
    Prim Care; 2009 Sep; 36(3):559-74. PubMed ID: 19616155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value for money from HPV vaccination and cervical screening.
    Ashton T; Sopina E
    Hum Vaccin Immunother; 2012 Jun; 8(6):828-30. PubMed ID: 22739689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the human papilloma vaccine on cervical cancer.
    Chan JK; Berek JS
    J Clin Oncol; 2007 Jul; 25(20):2975-82. PubMed ID: 17617529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer prevention in Australia: Planning for the future.
    Saville AM
    Cancer Cytopathol; 2016 Apr; 124(4):235-40. PubMed ID: 26619381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and early detection of cervical cancer in the UK.
    Foran C; Brennan A
    Br J Nurs; 2015 May 28-Jun 10; 24(10):S22-4, S26, S28-9. PubMed ID: 26018178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus vaccination in adolescence.
    Russell M; Raheja V; Jaiyesimi R
    Perspect Public Health; 2013 Nov; 133(6):320-4. PubMed ID: 24006173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
    Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
    Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R; Andrei C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):144-54. PubMed ID: 17595860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Wheeler CM
    Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To vaccinate or to screen--is that the question?
    Hann A; Peckham S
    Int J Health Plann Manage; 2008; 23(1):69-78. PubMed ID: 18317994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of cytology screening and HPV vaccination on the burden of cervical cancer.
    Tay K; Tay SK
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):154-9. PubMed ID: 21585695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.